Ligand validation:2UXL

U10: UBIQUINONE-10

U10 is a Ligand Of Interest in 2UXL designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
2UXL_U10_M_1310	29%	9%	0.217	0.921	2.76	1.7	13	11	1	0	76%	1
2BOZ_U10_M_1313	59%	20%	0.119	0.945	1.92	1.46	4	10	4	0	76%	1
3ZUM_U10_M_1308	59%	8%	0.116	0.939	2.76	1.89	13	13	4	0	76%	1
3ZUW_U10_M_1313	58%	9%	0.115	0.937	2.69	1.87	12	13	1	0	76%	1
2GNU_U10_M_1305	55%	9%	0.111	0.931	2.57	1.9	11	16	5	0	71%	1
2UWU_U10_M_1313	53%	11%	0.118	0.921	2.62	1.62	11	11	0	0	76%	1
4NV5_U10_B_501	74%	26%	0.074	0.99	1.64	1.37	2	8	6	0	52%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.